Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice
Prostate cancer (PCa) is the most commonly diagnosed cancer in men. The diagnosis is currently based on PSA levels, which are associated with overdiagnosis and overtreatment. Moreover, most PCas are localized tumours; hence, many patients with low-/very low-risk PCa could benefit from active surveil...
Main Authors: | Belén Pastor-Navarro, José Rubio-Briones, Ángel Borque-Fernando, Luis M. Esteban, Jose Luis Dominguez-Escrig, José Antonio López-Guerrero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/12/6266 |
Similar Items
-
Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance
by: Alexander Light, et al.
Published: (2022-12-01) -
Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
by: Darian Andreas, et al.
Published: (2016-07-01) -
MRI and Active Surveillance for Prostate Cancer
by: Angelo Porreca, et al.
Published: (2020-08-01) -
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
by: Salonee Shah, et al.
Published: (2021-05-01) -
Evaluation of various active surveillance protocols in prostate cancer
by: Kayhan Yılmaz, et al.
Published: (2014-06-01)